Demystifying the management of hypertriglyceridemia
EAS Academy. Tybjaerg-Hansen A. Apr 25, 2017; 175521 Topic: Therapy
Prof. Dr. Anne Tybjaerg-Hansen
Prof. Dr. Anne Tybjaerg-Hansen

Free Content is available to all users. Create a sign in with just your name and email.

Access EAS content "anytime, anywhere" with the EAS Academy App for iOS and Android

For any questions contact us at

Discussion Forum (0)
Rate & Comment (0)
A presentation by Professor Anne Tybjaerg-Hansen from Copenhagen University Hospital and Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. In this presentation we get basics on triglycerides and CVD risk and are also taken through the underlying genetic studies, primarily based on the data from Copenhagen. Furthermore Professor Tybjaerg-Hansen tells us about the new treatment targets that are being developed based on Mendelian randomization studies.
Code of conduct/disclaimer available in General Terms & Conditions
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.

Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.

Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.

Save Settings